The therapeutic options for patients with noninvasive or invasive breast cancer are complex
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …

Background Comparable data on the global and country-specific burden of neurological
disorders and their trends are crucial for health-care planning and resource allocation. The …

Background 18% of the world's population lives in India, and many states of India have
populations similar to those of large countries. Action to effectively improve population health in …

Several new systemic therapy options have become available for patients with metastatic
breast cancer, which have led to improvements in survival. In addition to patient and clinical …

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the
clinical management of patients with clear cell and non–clear cell renal carcinoma. These …

The NCCN Guidelines for Breast Cancer include up-to-date guidelines for clinical management
of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor…

These NCCN Guidelines Insights highlight the important updates/changes to the surgical
axillary staging, radiation therapy, and systemic therapy recommendations for hormone …

Tuberculosis (TB) in humans is characterized by formation of immune-rich granulomas in
infected tissues, the architecture and composition of which are thought to affect disease …

Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of
neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the …

Breast cancer is the most common malignancy in women in the United States and is second
only to lung cancer as a cause of cancer death. The overall management of breast cancer …